NCT00607763View on ClinicalTrials.gov

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Invasive CandidiasisEsophageal CandidiasisOropharyngeal CandidiasisCandidemia
Interventions
DRUG

Micafungin (Mycamine)

IV

Trial Locations (6)

40202

Louisville

64108

Kansas City

75390

Dallas

77030

Houston

90095

Los Angeles

92868

Orange

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00607763 - Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug | Biotech Hunter | Biotech Hunter